Moro AM - Search Results

1

Production of the first effective hyperimmune equine serum antivenom against Africanized bees.

Santos KS, Stephano MA, Marcelino JR, Ferreira VM, Rocha T, Caricati C, Higashi HG, Moro AM, Kalil JE, Malaspina O, Castro FF, Palma MS. Santos KS, et al. Among authors: moro am. PLoS One. 2013 Nov 13;8(11):e79971. doi: 10.1371/journal.pone.0079971. eCollection 2013. PLoS One. 2013. PMID: 24236166 Free PMC article.

2

Multiparametric analyses of hybridoma growth on glass cylinders in a packed-bed bioreactor system with internal aeration. Serum-supplemented and serum-free media comparison for MAb production.

Moro AM, Rodrigues MT, Gouvea MN, Silvestri ML, Kalil JE, Raw I. Moro AM, et al. J Immunol Methods. 1994 Nov 10;176(1):67-77. doi: 10.1016/0022-1759(94)90351-4. J Immunol Methods. 1994. PMID: 7963595

3

Comparison of humanized IgG and FvFc anti-CD3 monoclonal antibodies expressed in CHO cells.

Serpieri F, Inocencio A, de Oliveira JM, Pimenta AA Jr, Garbuio A, Kalil J, Brigido MM, Moro AM. Serpieri F, et al. Among authors: moro am. Mol Biotechnol. 2010 Jul;45(3):218-25. doi: 10.1007/s12033-010-9269-2. Mol Biotechnol. 2010. PMID: 20336495

4

Anti-digoxin Fab variants generated by phage display.

Murata VM, Schmidt MC, Kalil J, Tsuruta LR, Moro AM. Murata VM, et al. Among authors: moro am. Mol Biotechnol. 2013 Jun;54(2):269-77. doi: 10.1007/s12033-012-9564-1. Mol Biotechnol. 2013. PMID: 23359127

5

Tetanus antitoxin potency assessment by surface plasmon resonance and ToBI test.

Quintilio W, Kapronezai J, Takata DY, Marcelino JR, Moro AM. Quintilio W, et al. Among authors: moro am. Biologicals. 2019 Nov;62:107-110. doi: 10.1016/j.biologicals.2019.09.005. Epub 2019 Sep 11. Biologicals. 2019. PMID: 31519539

6

An oligoclonal combination of human monoclonal antibodies able to neutralize tetanus toxin in vivo.

Aliprandini E, Takata DY, Lepique A, Kalil J, Boscardin SB, Moro AM. Aliprandini E, et al. Among authors: moro am. Toxicon X. 2019 Jan 18;2:100006. doi: 10.1016/j.toxcx.2019.100006. eCollection 2019 Apr. Toxicon X. 2019. PMID: 32550563 Free PMC article.

7

Humanization of the anti-CD18 antibody 6.7: an unexpected effect of a framework residue in binding to antigen.

Caldas C, Coelho V, Kalil J, Moro AM, Maranhão AQ, Brígido MM. Caldas C, et al. Among authors: moro am. Mol Immunol. 2003 May;39(15):941-52. doi: 10.1016/s0161-5890(03)00022-1. Mol Immunol. 2003. PMID: 12695120

8

Novel humanized anti-CD3 antibodies induce a predominantly immunoregulatory profile in human peripheral blood mononuclear cells.

Silva HM, Vieira PM, Costa PL, Pimentel BM, Moro AM, Kalil J, Maranhão AQ, Coelho V, Brigido MM. Silva HM, et al. Among authors: moro am. Immunol Lett. 2009 Aug 15;125(2):129-36. doi: 10.1016/j.imlet.2009.06.009. Epub 2009 Jun 30. Immunol Lett. 2009. PMID: 19573559 Free article.

9

Human Recombinant Fab Fragment Neutralizes Shiga Toxin Type 2 Cytotoxic Effects in vitro and in vivo.

Luz D, Amaral MM, Sacerdoti F, Bernal AM, Quintilio W, Moro AM, Palermo MS, Ibarra C, Piazza RMF. Luz D, et al. Among authors: moro am. Toxins (Basel). 2018 Dec 2;10(12):508. doi: 10.3390/toxins10120508. Toxins (Basel). 2018. PMID: 30513821 Free PMC article.

10

Rebmab200, a humanized monoclonal antibody targeting the sodium phosphate transporter NaPi2b displays strong immune mediated cytotoxicity against cancer: a novel reagent for targeted antibody therapy of cancer.

Lopes dos Santos M, Yeda FP, Tsuruta LR, Horta BB, Pimenta AA Jr, Degaki TL, Soares IC, Tuma MC, Okamoto OK, Alves VA, Old LJ, Ritter G, Moro AM. Lopes dos Santos M, et al. Among authors: moro am. PLoS One. 2013 Jul 31;8(7):e70332. doi: 10.1371/journal.pone.0070332. Print 2013. PLoS One. 2013. PMID: 23936189 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page